Isofol Medical AB (ISOFOL)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Isofol Medical AB (ISOFOL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014069
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Isofol Medical AB (Isofol) is a clinical stage pharmaceutical company developing folate-based therapies for the treatment of cancer patients. The company’s clinical lead candidate Modufolin, a metabolite is under clinical phase I/II development being evaluated for the treatment of colorectal cancer and osteosarcoma. Isofol’s product helps in improving efficacy and reducing side effects of antimetabolites in cancer treatments. Isofol’s focuses to improve the outlook of cancer patients undergoing chemotherapy treatments It also offers research and development services. The company works in collaboration with Merck & Cie , Recipharm AB. Isofol is headquartered in Gothenburg, Sweden.

Isofol Medical AB (ISOFOL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Isofol Medical AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Isofol Medical AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Isofol Medical AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Isofol Medical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Isofol Medical AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Isofol Medical AB, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Isofol Medical Raises USD1.2 Million in Venture Financing 10
Licensing Agreements 11
Isofol Medical Enters Into Licensing Agreement With Merck For Modufolin 11
Equity Offering 12
Isofol Medical Raises USD48.6 Million in IPO 12
Isofol Medical Raises USD4.7 Million in Public Offering of Shares 13
Isofol Medical AB – Key Competitors 14
Isofol Medical AB – Key Employees 15
Isofol Medical AB – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Isofol Medical AB, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Isofol Medical AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Isofol Medical AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Isofol Medical AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Isofol Medical AB, Deals By Therapy Area, 2011 to YTD 2017 8
Isofol Medical AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Isofol Medical Raises USD1.2 Million in Venture Financing 10
Isofol Medical Enters Into Licensing Agreement With Merck For Modufolin 11
Isofol Medical Raises USD48.6 Million in IPO 12
Isofol Medical Raises USD4.7 Million in Public Offering of Shares 13
Isofol Medical AB, Key Competitors 14
Isofol Medical AB, Key Employees 15

★海外企業調査レポート[Isofol Medical AB (ISOFOL)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • UNIQA Romania:企業の戦略・SWOT・財務情報
    UNIQA Romania - Strategy, SWOT and Corporate Finance Report Summary UNIQA Romania - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • CVRx Inc:医療機器:M&Aディール及び事業提携情報
    Summary CVRx Inc (CVRx) is a medical device company that develops and designs implantable device. The company provides barostim neo system, which is designed to trigger the body’s natural blood flow regulation system to treat high blood pressure and heart failure. Its products are used in the treatm …
  • InVitae Corp (NVTA):製薬・医療:M&Aディール及び事業提携情報
    Summary Invitae Corp (Invitae), formerly Locus Development Inc, is a genetic information company which processes DNA-containing samples, analyzes information about patient-specific genetic variation and generates test reports for clinicians and their patients. The company’s portfolio of diagnostic t …
  • G4S plc:企業の戦略・SWOT・財務情報
    G4S plc - Strategy, SWOT and Corporate Finance Report Summary G4S plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Central Petroleum Ltd (CTP):企業の財務・戦略的SWOT分析
    Summary Central Petroleum Ltd (CPL) operates as an oil and gas company that offers exploration and development services. The company develops, produces, processes and markets hydrocarbons. It operates its oil and gas assets in Amadeus basin, Pedirka basin, Georgina basin, and Wiso basin. CPL’s Amade …
  • eFront S.A.:企業の戦略的SWOT分析
    eFront S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Ypsomed Holding AG (YPSN):企業の製品パイプライン分析
    Summary Ypsomed Holding AG (Ypsomed) is a medical device company that designs, develops and manufactures injection and infusion systems for self-medication and offers related services. It offers autoinjectors, dual chamber pens, and pen injectors. The company also offers services ranging from design …
  • KemPharm Inc (KMPH):製薬・医療:M&Aディール及び事業提携情報
    Summary KemPharm Inc (KemPharm) is a clinical-stage specialty pharmaceutical company that offers discovery and development of proprietary new molecular entity prodrugs. The company’s product pipeline includes KP415, methylphenidate drug for ADHD; KP201/IR, KP511/ER, KP606/IR and KP746 drugs for the …
  • Deciphera Pharmaceuticals LLC (DCPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Deciphera Pharmaceuticals LLC (Deciphera Pharmaceuticals) is a research and development company that develops, designs, and commercializes kinase inhibiting drugs. The company provides clinical pipeline of kinase inhibitors such as tumor-targeted therapies and immuno-targeted therapies. It u …
  • California Resources Corp (CRC):企業の財務・戦略的SWOT分析
    California Resources Corp (CRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Vistra Energy Corp (VST):電力:M&Aディール及び事業提携情報
    Summary Vistra Energy Corp (Vistra Energy) is an investment holding company engaged in operation of integrated power business. The company through its subsidiaries is involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, and retail sales of e …
  • Mattress Firm Holding Corp.:企業のM&A・事業提携・投資動向
    Mattress Firm Holding Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mattress Firm Holding Corp. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Uniper SE (UN01):企業の財務・戦略的SWOT分析
    Uniper SE (UN01) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Bayer HealthCare Pharmaceuticals:医療機器:M&Aディール及び事業提携情報
    Summary Bayer HealthCare Pharmaceuticals (Bayer Healthcare), formerly Bayer Schering Pharma AG, a subsidiary of Bayer AG, is the pharmaceutical company that develops, manufactures and markets prescription products in the areas of general medicine and specialty medicine. The company offer prescriptio …
  • Sun Life Hong Kong Limited:企業の戦略・SWOT・財務分析
    Sun Life Hong Kong Limited - Strategy, SWOT and Corporate Finance Report Summary Sun Life Hong Kong Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Lexmark International Inc:企業の戦略的SWOT分析
    Lexmark International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • China Petroleum & Chemical Corporation (600028)-エネルギー分野:企業M&A・提携分析
    Summary China Petroleum & Chemical Corporation (Sinopec), a subsidiary of China Petrochemical Corporation, is a vertically integrated energy and chemical company. It is involved in the oil and gas exploration and production, extraction, pipeline transmission and marketing; oil refining; and producti …
  • Zion Oil & Gas Inc (ZN):石油・ガス:M&Aディール及び事業提携情報
    Summary Zion Oil & Gas Inc (Zion Oil) is an oil and gas company that explores and produces oil and gas properties in Israel. The company offers services such as geophysical, geological, and other science-based studies and surveys to support oil and gas exploration and development services. It holds …
  • Flexpoint Sensor Systems Inc (FLXT):企業の財務・戦略的SWOT分析
    Summary Flexpoint Sensor Systems Inc (Flexpoint Sensor) is a supplier of thin film sensing technology. The company offers designing, consulting, development and manufacturing services to the adoption of the bend sensor technology. It provides flexible sensors. Flexpoint Sensor’ bend sensor allows th …
  • Liberty International Holdings Inc:企業の戦略・SWOT・財務情報
    Liberty International Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Liberty International Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆